Industry News
Cheap anti-malaria drug shows promise against colorectal cancer
Nov 19, 2014
Artesunate - a cheap and commonly used anti-malaria drug - shows promising results in a pilot study that tested it on colorectal cancer patients before tumor-removal surgery. Read More
Genes and sun behaviors during childhood may play large role in future melanoma risk
Nov 19, 2014
A longitudinal study established a link between different ultraviolet (UV) exposure measures in children, such as the number of waterside vacations or sunburns, and biomarkers of melanoma risk... Read More
Patients with advanced papillary kidney cancer respond well to a combination of two existing anti-cancer drugs
Nov 19, 2014
Researchers have found that patients with an advanced form of kidney cancer, for which there is no standard treatment and a very poor prognosis, respond well to a combination of two existing... Read More
First demonstration of anti-cancer activity for AG-120, an inhibitor of the IDH1 mutation, in patients with advanced leukaemia
Nov 19, 2014
A phase I trial of the first drug designed to inhibit the cancer-causing activity of a mutated enzyme known as isocitrate dehydrogenase (IDH) 1, which is involved in cell metabolism, has shown... Read More
Childhood central nervous system cancer affects identity in adulthood
Nov 19, 2014
Patients who have been treated for cancer of the central nervous system (brain tumours) in childhood or adolescence can show affected self-perception and self-identity in adulthood. Read More
News from Annals of Internal Medicine Supplement Nov. 18 2014
Nov 19, 2014
1. Recommending MyFitnessPal to obese patients unlikely to produce weight lossUsing a smartphone app is unlikely to produce substantial weight loss for most overweight patients, according to an... Read More
Researchers discover new way to fight chronic myeloid leukemia
Nov 19, 2014
Chronic myeloid leukemia develops when a gene mutates and causes an enzyme to become hyperactive, causing blood-forming stem cells in the bone marrow to grow rapidly into abnormal cells. Read More
Chemistry trick may herald transformational next-generation RNAi therapeutics aimed at cancer, viral infections and more
Nov 19, 2014
Small pieces of synthetic RNA trigger a RNA interference (RNAi) response that holds great therapeutic potential to treat a number of diseases, especially cancer and pandemic viruses. Read More
Novel delivery platform identified that leads to the inhibition of microRNA activity - and the control of cancer growth
Nov 19, 2014
Since the discovery that microRNAs play key roles in regulating human disease, the hope has been that these short non-coding RNA molecules could be translated into a therapeutic strategy for the... Read More
DAPT study favored 30 over 12 months of DAPT for lower clot and heart attack risk
Nov 19, 2014
The Harvard Clinical Research Institute (HCRI) has announced results of the DAPT Study, a major international study that investigated the duration of dual antiplatelet therapy (DAPT, the combination... Read More
Previous Page Next Page